PMC:7441788 / 19721-20203
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T185 | 24-29 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
| T186 | 252-257 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T187 | 261-264 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 3–5 |
| T188 | 286-291 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T240 | 24-29 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
| T241 | 58-63 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T242 | 77-89 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T243 | 90-95 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T244 | 112-117 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T245 | 196-208 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T246 | 423-427 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T137 | 77-89 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T138 | 196-208 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T148 | 0-270 | Sentence | denotes | Gautret et al.[57] Open label, nonrandom cohort study HCQ group: n = 12; HCQ＋azithromycin group: n = 6; control group: n = 12 HCQ (200 mg/3 times/day for 10 days) HCQ alone or in combination with azithromycin could effectively eliminate nasopharyngeal virus in 3–5 days. |
| T149 | 271-332 | Sentence | denotes | Nasopharyngeal virus determination was used as main endpoint. |
| T150 | 333-482 | Sentence | denotes | Small sample size; Six patients dropped out due to critical illness or intolerance to the drug; Lack of clinical outcomes; Limited follow-up results. |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 686 | 54-57 | Chemical | denotes | HCQ | MESH:D006886 |
| 687 | 73-76 | Chemical | denotes | HCQ | MESH:D006886 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T122 | 252-257 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T123 | 286-291 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 686 | 54-57 | Chemical | denotes | HCQ | MESH:D006886 |
| 687 | 73-76 | Chemical | denotes | HCQ | MESH:D006886 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T148 | 0-270 | Sentence | denotes | Gautret et al.[57] Open label, nonrandom cohort study HCQ group: n = 12; HCQ＋azithromycin group: n = 6; control group: n = 12 HCQ (200 mg/3 times/day for 10 days) HCQ alone or in combination with azithromycin could effectively eliminate nasopharyngeal virus in 3–5 days. |
| T149 | 271-332 | Sentence | denotes | Nasopharyngeal virus determination was used as main endpoint. |
| T150 | 333-482 | Sentence | denotes | Small sample size; Six patients dropped out due to critical illness or intolerance to the drug; Lack of clinical outcomes; Limited follow-up results. |